Fluvoxamine for the treatment of anxiety disorders in children and adolescents.

Suppr

超能文献

作者信息

Isaacs E

出版信息

N Engl J Med. 2001 Aug 9;345(6):466-7. doi: 10.1056/NEJM200108093450615.

DOI:10.1056/NEJM200108093450615

PMID:11496864

Abstract

摘要

相似文献

Fluvoxamine for the treatment of anxiety disorders in children and adolescents.

N Engl J Med. 2001 Aug 9;345(6):466-7. doi: 10.1056/NEJM200108093450615.

Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group.

N Engl J Med. 2001 Apr 26;344(17):1279-85. doi: 10.1056/NEJM200104263441703.

Pilot study: fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer.

J Am Acad Child Adolesc Psychiatry. 2005 Dec;44(12):1258-62. doi: 10.1097/01.chi.0000181042.29208.eb.

Drug treatment of anxiety disorders in children.

N Engl J Med. 2001 Apr 26;344(17):1326-7. doi: 10.1056/NEJM200104263441711.

Observation of QTc prolongation in an adolescent girl during fluvoxamine pharmacotherapy.

J Child Adolesc Psychopharmacol. 2009 Oct;19(5):591-2. doi: 10.1089/cap.2008.0136.

Extended-release fluvoxamine (Luvox CR).

Med Lett Drugs Ther. 2008 Jun 30;50(1289):50-1.

Clinical impact of fluvoxamine-mediated long QTU syndrome.

Eur J Clin Pharmacol. 2012 Jan;68(1):109-11. doi: 10.1007/s00228-011-1091-7. Epub 2011 Jun 29.

Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents.

J Child Adolesc Psychopharmacol. 2009 Apr;19(2):119-26. doi: 10.1089/cap.2008.040.

The luvox debate.

Time. 2001 May 7;157(18):76.

Fluvoxamine approved for treating OCD in children.

J Psychosoc Nurs Ment Health Serv. 2001 Jan;39(1):11.

引用本文的文献

Serum Concentration-Dose Relationship and Modulation Factors in Children and Adolescents Treated with Fluvoxamine.

Pharmaceutics. 2024 Jun 6;16(6):772. doi: 10.3390/pharmaceutics16060772.

Whole-Brain Resting-State Functional Connectivity Patterns Associated With Pediatric Anxiety and Involuntary Attention Capture.

Biol Psychiatry Glob Open Sci. 2021 Sep;1(3):229-238. doi: 10.1016/j.bpsgos.2021.05.007. Epub 2021 Jun 2.

Attention Alterations in Pediatric Anxiety: Evidence From Behavior and Neuroimaging.

Biol Psychiatry. 2021 Apr 1;89(7):726-734. doi: 10.1016/j.biopsych.2020.07.016. Epub 2020 Aug 1.

Overcontrol and neural response to errors in pediatric anxiety disorders.

J Anxiety Disord. 2020 May;72:102224. doi: 10.1016/j.janxdis.2020.102224. Epub 2020 Apr 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Fluvoxamine for the treatment of anxiety disorders in children and adolescents.

N Engl J Med. 2001 Aug 9;345(6):466-7. doi: 10.1056/NEJM200108093450615.

Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group.

N Engl J Med. 2001 Apr 26;344(17):1279-85. doi: 10.1056/NEJM200104263441703.

Pilot study: fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer.

J Am Acad Child Adolesc Psychiatry. 2005 Dec;44(12):1258-62. doi: 10.1097/01.chi.0000181042.29208.eb.

Drug treatment of anxiety disorders in children.

N Engl J Med. 2001 Apr 26;344(17):1326-7. doi: 10.1056/NEJM200104263441711.

Observation of QTc prolongation in an adolescent girl during fluvoxamine pharmacotherapy.

J Child Adolesc Psychopharmacol. 2009 Oct;19(5):591-2. doi: 10.1089/cap.2008.0136.

Extended-release fluvoxamine (Luvox CR).

Med Lett Drugs Ther. 2008 Jun 30;50(1289):50-1.

Clinical impact of fluvoxamine-mediated long QTU syndrome.

Eur J Clin Pharmacol. 2012 Jan;68(1):109-11. doi: 10.1007/s00228-011-1091-7. Epub 2011 Jun 29.

Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents.

J Child Adolesc Psychopharmacol. 2009 Apr;19(2):119-26. doi: 10.1089/cap.2008.040.

The luvox debate.

Time. 2001 May 7;157(18):76.

Fluvoxamine approved for treating OCD in children.

J Psychosoc Nurs Ment Health Serv. 2001 Jan;39(1):11.

引用本文的文献

Serum Concentration-Dose Relationship and Modulation Factors in Children and Adolescents Treated with Fluvoxamine.

Pharmaceutics. 2024 Jun 6;16(6):772. doi: 10.3390/pharmaceutics16060772.

Whole-Brain Resting-State Functional Connectivity Patterns Associated With Pediatric Anxiety and Involuntary Attention Capture.

Biol Psychiatry Glob Open Sci. 2021 Sep;1(3):229-238. doi: 10.1016/j.bpsgos.2021.05.007. Epub 2021 Jun 2.

Attention Alterations in Pediatric Anxiety: Evidence From Behavior and Neuroimaging.

Biol Psychiatry. 2021 Apr 1;89(7):726-734. doi: 10.1016/j.biopsych.2020.07.016. Epub 2020 Aug 1.

Overcontrol and neural response to errors in pediatric anxiety disorders.

J Anxiety Disord. 2020 May;72:102224. doi: 10.1016/j.janxdis.2020.102224. Epub 2020 Apr 6.